Rantapää Dahlqvist S - Search Results

1

Interleukin-6 and soluble interleukin-2 receptor alpha-markers of inflammation in patients with psoriatic arthritis?

Alenius GM, Eriksson C, Rantapää Dahlqvist S. Alenius GM, et al. Among authors: rantapaa dahlqvist s. Clin Exp Rheumatol. 2009 Jan-Feb;27(1):120-3. Clin Exp Rheumatol. 2009. PMID: 19327240

2

Muscle performance, electromyography and fibre type composition in fibromyalgia and work-related myalgia.

Elert JE, Rantapää-Dahlqvist SB, Henriksson-Larsén K, Lorentzon R, Gerdlé BU. Elert JE, et al. Among authors: rantapaa dahlqvist sb. Scand J Rheumatol. 1992;21(1):28-34. doi: 10.3109/03009749209095059. Scand J Rheumatol. 1992. PMID: 1570484

3

Plasminogen activator inhibitor and von Willebrand factor in polymyalgia rheumatica.

Uddhammar A, Rantapåå-Dahlqvist S, Nilsson TK. Uddhammar A, et al. Among authors: rantapaa dahlqvist s. Clin Rheumatol. 1992 Jun;11(2):211-5. doi: 10.1007/BF02207959. Clin Rheumatol. 1992. PMID: 1617895

4

Prevalence of anti-endothelial cell antibodies in patients with autoimmune diseases.

Nylander Lundqvist E, Back O, Nilsson TK, Rantapaa-Dahlqvist S. Nylander Lundqvist E, et al. Among authors: rantapaa dahlqvist s. Clin Rheumatol. 1992 Jun;11(2):248-53. doi: 10.1007/BF02207967. Clin Rheumatol. 1992. PMID: 1617902

5

Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis.

Rantapää-Dahlqvist S, Wållberg-Jonsson S, Dahlén G. Rantapää-Dahlqvist S, et al. Ann Rheum Dis. 1991 Jun;50(6):366-8. doi: 10.1136/ard.50.6.366. Ann Rheum Dis. 1991. PMID: 1829348 Free PMC article.

6

Is HLA B27 antigen a predictor of cardiac or pulmonary disease in patients with rheumatoid arthritis?

Rantapää Dahlqvist S, Backman C, Bjerle P, Johnson O. Rantapää Dahlqvist S, et al. Scand J Rheumatol. 1991;20(3):165-71. doi: 10.3109/03009749109103017. Scand J Rheumatol. 1991. PMID: 2068538

7

The effect of CPH 82 on the growth of human lymphocytes in vitro. Definition of cytobiological action.

Rantapää Dahlqvist S, Norberg B, Sondell K, Nordenson I, Holmgren G. Rantapää Dahlqvist S, et al. Br J Rheumatol. 1989 Oct;28(5):418-21. doi: 10.1093/rheumatology/28.5.418. Br J Rheumatol. 1989. PMID: 2790402

8

Lipoprotein(a) in relation to acute phase reaction in patients with rheumatoid arthritis and polymyalgia rheumatica.

Wållberg-Jonsson S, Uddhammar A, Dahlén G, Rantapää-Dahlqvist S. Wållberg-Jonsson S, et al. Among authors: rantapaa dahlqvist s. Scand J Clin Lab Invest. 1995 Jul;55(4):309-15. doi: 10.3109/00365519509104968. Scand J Clin Lab Invest. 1995. PMID: 7569733

9

Cell cycle effects of the anti-rheumatic agent CPH82.

Rantapää Dahlqvist S, Landberg G, Roos G, Norberg B. Rantapää Dahlqvist S, et al. Br J Rheumatol. 1994 Apr;33(4):327-31. doi: 10.1093/rheumatology/33.4.327. Br J Rheumatol. 1994. PMID: 7908845

10

Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis.

Wållberg-Jonsson S, Dahlén GH, Nilsson TK, Rånby M, Rantapää-Dahlqvist S. Wållberg-Jonsson S, et al. Among authors: rantapaa dahlqvist s. Clin Rheumatol. 1993 Sep;12(3):318-24. doi: 10.1007/BF02231572. Clin Rheumatol. 1993. PMID: 8258230

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results